CytomX Therapeutics
CTMX
CTMX
119 hedge funds and large institutions have $637M invested in CytomX Therapeutics in 2017 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 47 increasing their positions, 24 reducing their positions, and 12 closing their positions.
Holders
119
Holders Change
+22
Holders Change %
+22.68%
% of All Funds
2.7%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
34
Increased
47
Reduced
24
Closed
12
Calls
$21K
Puts
$50K
Net Calls
-$29K
Net Calls Change
-$29K
Top Buyers
1 |
TG
1
TRV GP
Boston,
Massachusetts
|
$70.1M |
2 |
PA
2
Perceptive Advisors
New York
|
$52.6M |
3 |
3
BlackRock
New York
|
$55.9M |
4 |
PAMU
4
Pictet Asset Management (UK)
London,
United Kingdom
|
$12.4M |
5 |
5
Invesco
Atlanta,
Georgia
|
$10.8M |